Latest Market Challenges News

Page 57 of 71
Aroa Biosurgery has reported FY25 results that exceed revenue guidance and deliver a positive normalised EBITDA, setting the stage for ambitious growth and reimbursement expansion in FY26.
Ada Torres
Ada Torres
29 May 2025
Champion Iron Limited reported a 5% increase in revenue to C$1.606 billion for the year ended March 31, 2025, while net profit fell sharply by 39% to C$142 million. The company declared an unfranked interim dividend of C$0.10 per share.
Maxwell Dee
Maxwell Dee
29 May 2025
Yancoal Australia Ltd reported robust 2024 financial results and outlined key corporate governance actions at its 2025 Annual General Meeting, reinforcing its position as a leading coal producer amid market challenges.
Maxwell Dee
Maxwell Dee
28 May 2025
ALS Limited reported a robust FY25 with $3 billion revenue driven by Life Sciences growth and resilient Commodities, announcing a $350 million equity raise to fund strategic expansion.
Victor Sage
Victor Sage
27 May 2025
ALS Limited reported a 16% revenue increase to nearly $3 billion in FY2025, driven by acquisitions and organic growth, while underlying net profit after tax dipped slightly. The company announced a $350 million equity raise to fund expansion and sustainability initiatives.
Victor Sage
Victor Sage
27 May 2025
Metro Performance Glass reported a net loss for FY25 amid market softness but outlines a clear recovery plan with leadership changes and an equity raise to strengthen its position.
Victor Sage
Victor Sage
27 May 2025
Yowie Group has posted its first profitable seasonal quarter, driven by strategic cost control and product improvements, but faces ongoing capital challenges due to a significant loan default by Keybridge Capital.
Victor Sage
Victor Sage
26 May 2025
TruScreen Group Ltd reports a dip in FY25 sales but forecasts a robust rebound in FY26 driven by resumed programs and expansion in key emerging markets. Strategic partnerships and AI-enabled technology underpin its growth ambitions.
Ada Torres
Ada Torres
26 May 2025
Proteomics International has validated its PromarkerEndo blood test as a highly accurate, non-invasive diagnostic tool for endometriosis, with commercial launch planned in Australia for Q3 2025. The test promises to reduce the average seven-year diagnostic delay by providing a simple risk score applicable across all disease stages.
Ada Torres
Ada Torres
26 May 2025
Sietel Limited’s half-year results to March 2025 reveal an 11% revenue drop and a near 50% plunge in net profit, reflecting tough market conditions in property leasing and startup investments.
Victor Sage
Victor Sage
23 May 2025
Australis Oil & Gas reported a robust 2024 performance with strong safety and environmental records, maintaining strategic focus on its Tuscaloosa Marine Shale asset despite challenging market conditions.
Maxwell Dee
Maxwell Dee
22 May 2025
Australian Agricultural Company Limited (AACo) reported a 14% rise in operating profit to $58.4 million for FY25, driven by increased sales volumes and disciplined cost control despite challenging market conditions. The company also marked a significant reduction in statutory loss, signaling improved financial resilience.
Ada Torres
Ada Torres
22 May 2025